Home/Filings/4/0000921895-10-001596
4//SEC Filing

ORE PHARMACEUTICAL HOLDINGS INC. 4

Accession 0000921895-10-001596

CIK 0001043914operating

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 8:20 PM ET

Size

9.1 KB

Accession

0000921895-10-001596

Insider Transaction Report

Form 4
Period: 2010-10-27
Transactions
  • Purchase

    Common Stock, $.01 Par Value

    2010-10-27$0.26/sh+125,000$31,8753,500,000 total
  • Purchase

    Common Stock, $.01 Par Value

    2010-10-28$0.26/sh+68,000$17,3403,568,000 total
Transactions
  • Purchase

    Common Stock, $.01 Par Value

    2010-10-28$0.26/sh+68,000$17,3403,568,000 total
  • Purchase

    Common Stock, $.01 Par Value

    2010-10-27$0.26/sh+125,000$31,8753,500,000 total
Footnotes (2)
  • [F1]This Form 4 is filed jointly by Steel Partners, Ltd. ("SPL") and Warren G. Lichtenstein. Mr. Lichtenstein may be deemed to be a 10% owner of the Issuer and SPL is a 10% owner of the Issuer.
  • [F2]The securities reported in this Form 4 are owned directly by SPL, and owned indirectly by Mr. Lichtenstein by virtue of his position as the Chief Executive Officer and sole Director of SPL. Mr. Lichtenstein disclaims beneficial ownership of the shares owned by SPL except to the extent of his pecuniary interest therein.

Issuer

ORE PHARMACEUTICAL HOLDINGS INC.

CIK 0001043914

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001043914

Filing Metadata

Form type
4
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 8:20 PM ET
Size
9.1 KB